U.S. Markets closed

Introducing Virbac (EPA:VIRP), The Stock That Dropped 31% In The Last Three Years

Simply Wall St

As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. We regret to report that long term Virbac SA (EPA:VIRP) shareholders have had that experience, with the share price dropping 31% in three years, versus a market return of about 40%.

Check out our latest analysis for Virbac

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

Over the three years that the share price declined, Virbac’s earnings per share (EPS) dropped significantly, falling to a loss. Extraordinary items contributed to this situation. Since the company has fallen to a loss making position, it’s hard to compare the change in EPS with the share price change. But it’s safe to say we’d generally expect the share price to be lower as a result!

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

ENXTPA:VIRP Past and Future Earnings, March 18th 2019

It might be well worthwhile taking a look at our free report on Virbac’s earnings, revenue and cash flow.

A Different Perspective

It’s good to see that Virbac has rewarded shareholders with a total shareholder return of 14% in the last twelve months. That certainly beats the loss of about 6.1% per year over the last half decade. This makes us a little wary, but the business might have turned around its fortunes. You could get a better understanding of Virbac’s growth by checking out this more detailed historical graph of earnings, revenue and cash flow.

But note: Virbac may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on FR exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.